167 related articles for article (PubMed ID: 7914520)
21. Elafin is a potent inhibitor of proteinase 3.
Wiedow O; Lüademann J; Utecht B
Biochem Biophys Res Commun; 1991 Jan; 174(1):6-10. PubMed ID: 1989620
[TBL] [Abstract][Full Text] [Related]
22. Isolation of elafin and elastase-specific inhibitor (ESI) from bronchial secretions. Evidence of sequence homology and immunological cross-reactivity.
Sallenave JM; Marsden MD; Ryle AP
Biol Chem Hoppe Seyler; 1992 Jan; 373(1):27-33. PubMed ID: 1536690
[TBL] [Abstract][Full Text] [Related]
23. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
[TBL] [Abstract][Full Text] [Related]
24. The gene of the protease inhibitor SKALP/elafin is a member of the REST gene family.
Lundwall A; Ulvsback M
Biochem Biophys Res Commun; 1996 Apr; 221(2):323-7. PubMed ID: 8619854
[TBL] [Abstract][Full Text] [Related]
25. Accelerated evolution in inhibitor domains of porcine elafin family members.
Tamechika I; Itakura M; Saruta Y; Furukawa M; Kato A; Tachibana S; Hirose S
J Biol Chem; 1996 Mar; 271(12):7012-8. PubMed ID: 8636131
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of the inhibition of neutrophil proteinases by recombinant elafin and pre-elafin (trappin-2) expressed in Pichia pastoris.
Zani ML; Nobar SM; Lacour SA; Lemoine S; Boudier C; Bieth JG; Moreau T
Eur J Biochem; 2004 Jun; 271(12):2370-8. PubMed ID: 15182352
[TBL] [Abstract][Full Text] [Related]
27. Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin.
Guyot N; Zani ML; Berger P; Dallet-Choisy S; Moreau T
Biol Chem; 2005 Apr; 386(4):391-9. PubMed ID: 15899702
[TBL] [Abstract][Full Text] [Related]
28. Structural, biochemical, and cell biological aspects of the serine proteinase inhibitor SKALP/elafin/ESI.
Molhuizen HO; Schalkwijk J
Biol Chem Hoppe Seyler; 1995 Jan; 376(1):1-7. PubMed ID: 7612183
[TBL] [Abstract][Full Text] [Related]
29. The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core.
Schalkwijk J; Wiedow O; Hirose S
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):569-77. PubMed ID: 10359639
[TBL] [Abstract][Full Text] [Related]
30. Cryptic origin of SPAI, a plasma protein with a transglutaminase substrate domain and the WAP motif, revealed by in situ hybridization and immunohistochemistry.
Furukawa M; Suzuki Y; Ghoneim MA; Tachibana S; Hirose S
J Biol Chem; 1996 Nov; 271(47):29517-20. PubMed ID: 8939875
[TBL] [Abstract][Full Text] [Related]
31. Structural and antimicrobial properties of human pre-elafin/trappin-2 and derived peptides against Pseudomonas aeruginosa.
Bellemare A; Vernoux N; Morin S; Gagné SM; Bourbonnais Y
BMC Microbiol; 2010 Oct; 10():253. PubMed ID: 20932308
[TBL] [Abstract][Full Text] [Related]
32. Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung.
Tremblay GM; Sallenave JM; Israél-Assayag E; Cormier Y; Gauldie J
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1092-8. PubMed ID: 8887613
[TBL] [Abstract][Full Text] [Related]
33. Cross-linking of galectin 3, a galactose-binding protein of mammalian cells, by tissue-type transglutaminase.
Mehul B; Bawumia S; Hughes RC
FEBS Lett; 1995 Feb; 360(2):160-4. PubMed ID: 7875321
[TBL] [Abstract][Full Text] [Related]
34. Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa. Transglutaminase-catalyzed cross-linking to cellular and extracellular structures.
Jensen PH; Lorand L; Ebbesen P; Gliemann J
Eur J Biochem; 1993 May; 214(1):141-6. PubMed ID: 8099547
[TBL] [Abstract][Full Text] [Related]
35. Discovery of a new type of proteinase inhibitor family whose members have an anchoring sequence.
Hirose S; Furukawa M; Tamechika I; Itakura M; Kato A; Suzuki Y; Kuroki J; Tachibana S
Adv Exp Med Biol; 1996; 389():43-9. PubMed ID: 8860992
[No Abstract] [Full Text] [Related]
36. Synthesis and structure-activity relationships of elafin, an elastase-specific inhibitor.
Tsunemi M; Kato H; Nishiuchi Y; Kumagaye S; Sakakibara S
Biochem Biophys Res Commun; 1992 Jun; 185(3):967-73. PubMed ID: 1627147
[TBL] [Abstract][Full Text] [Related]
37. Characterization of human pre-elafin mutants: full antipeptidase activity is essential to preserve lung tissue integrity in experimental emphysema.
Doucet A; Bouchard D; Janelle MF; Bellemare A; Gagné S; Tremblay GM; Bourbonnais Y
Biochem J; 2007 Aug; 405(3):455-63. PubMed ID: 17489739
[TBL] [Abstract][Full Text] [Related]
38. alpha(2)-plasmin inhibitor is a substrate for tissue transglutaminase: an in vitro study.
Hevessy Z; Patthy A; Kárpáti L; Muszbek L
Thromb Res; 2000 Aug; 99(4):399-406. PubMed ID: 10963790
[No Abstract] [Full Text] [Related]
39. Mapping the heparin-binding site of mucus proteinase inhibitor.
Mellet P; Ermolieff J; Bieth JG
Biochemistry; 1995 Feb; 34(8):2645-52. PubMed ID: 7873546
[TBL] [Abstract][Full Text] [Related]
40. Cross-linking of elafin/SKALP to elastic fibers in photodamaged skin: too much of a good thing?
Schalkwijk J
J Invest Dermatol; 2007 Jun; 127(6):1286-7. PubMed ID: 17502858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
